This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Lupus pernio

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This is a cutaneous manifestation of sarcoid in which blue-red nodules may be present on the nose, face and hands.

Click here for an example image of this conditon

Lupus pernio (LP) is pathognomonic of sarcoidosis (1)

  • it is a chronic papulonodular eruption which consists of violaceous, indurated papules, nodules, and plaques, these lesions may become hardened and fibrotic
  • more common in women than in men (2)
  • commonly seen around the central face, and especially the alar rim of the nose
  • there can be associated
    • lytic and cystic bone lesions - especially in the hands and feet
    • granulomatous inflammation of the upper respiratory tract with resulting airway obstruciton even in mild cases e.g. - lesions on the nasal rim is associated with sarcoidosis of the lungs (in up to 75% cases) and upper respiratory tract (in up to 50% of cases) (1)

Reference:

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.